Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF vs Cyclosporin in Idiopathic Membranous Nephropathy
NCT03170323Phase 4Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Jul 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mycophenolate mofetil in idiopathic membranous nephropathy (IMN) (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoints: Complete Remission at 1 year and Partial Remission at 1 year. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
idiopathic membranous nephropathy (IMN)
Beyond the preview
Go deeper on NCT03170323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03170323.